Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review. Braz. J. Pharm. Sci. 2017;53(1):e16102-. doi:10.1590/s2175-97902017000116102